Long-term treatment of spasticity in children with cerebral palsy.
The author's clinical experience with the use of dantrolene in children with cerebral palsy is discussed. The medication is found to be the drug of choice for children with spastic cerebral palsy.
D002547:Cerebral Palsy / Q000534:rehabilitation*; D002648:Child; D003620:Dantrolene / Q000009:adverse effects / Q000627:therapeutic use*; D005684:Gait; D006801:Humans; D008134:Long-Term Care; D009128:Muscle Spasticity / Q000534:rehabilitation
D003620:Dantrolene